Myskin®, keratinocytes on a polymer film patch for treatment of skin ulcers

Myskin® is an autologous keratinocyte-based active treatment product indicated for burns and non-healing wounds. Cultured keratinocytes are delivered on a chemically-defined transfer polymer film, which promotes the growth of skin cells and releases the cells upon exposure to the wound. A phase III clinical trial is aiming to assess the efficacy of Myskin® on healing burn wounds, and to evaluate reduction of pain and occurrence of infections over a 1 month time frame, compared to traditional gauze and patch dressing treatment.